Category : Business Post
GW-501516 or Cardarine(1) as it’s called was developed in the 1990s by a joint effort of two pharmaceuticals powerhouses GlaxoSmithKline and Ligand Pharmaceuticals. Originally set in motion at clinical developmental stages as a drug to forestall cardiovascular diseases especially tumor formation in different parts of the body like breasts, colon, and prostate.
Well done! Your Request Forward Successfully!.
Warning! Request already Forward Successfully!.
Please select the category that most closely reflects your concern about the List, so that we can review it and determine whether it violates our Community Guidelines or isn't appropriate for all viewers. Abusing this feature is also a violation of the Community Guidelines, so don't do it.
<p>Cardarine (GW501516) is a PPAR receptor agonist invented by Ligand Pharmaceuticals and GlaxoSmithKline in the 1990s. Cardarine was originally developed to treat obesity, diabetes, lipid strain, and cardiovascular diseases. Those who run blood work when using cardarine will notice that their cholesterol levels improve substantially.</p>
<p>Cardarine (GW501516) is a PPAR (Peroxisome proliferator-activated receptor) drug, which is also sold and marketed as a SARM (selective androgen receptor modulator). This drug started being researched in the early 1990’s by GlaxoSmithKline and Ligand Pharmaceuticals to treat diabetes, obesity, and heart disease.</p>